Back to Search

MURAT ARCASOY, MD

MD

Hematology & Oncology Physician

NPI: 1760420145Individual

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

99-01501(NC)

Research & Publications (20)

Erythropoiesis-stimulating agent use in cancer: preclinical and clinical perspectives.
PMID 18676735·Clin Cancer Res·2008
6-review
The non-haematopoietic biological effects of erythropoietin.
PMID 18324962·Br J Haematol·2008
6-review
Aplastic anaemia as an autoimmune complication of thymoma.
PMID 17355260·Br J Haematol·2007
5-case
Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor.
PMID 15982354·Br J Haematol·2005
8-other
Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
PMID 15878737·Biochim Biophys Acta·2005
7-preclinical
Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.
PMID 15671524·Clin Cancer Res·2005
8-other
Erythropoietin and erythropoietin receptor expression in human prostate cancer.
PMID 15467711·Mod Pathol·2005
4-observational
Expression of erythropoietin receptor splice variants in human cancer.
PMID 12878211·Biochem Biophys Res Commun·2003
7-preclinical
Functional significance of erythropoietin receptor expression in breast cancer.
PMID 12118093·Lab Invest·2002
7-preclinical
A novel mutation in the erythropoietin receptor gene is associated with familial erythrocytosis.
PMID 11929803·Blood·2002
5-case
Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
PMID 11722594·Eur J Haematol·2001
7-preclinical
Constitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathway.
PMID 19133231·Biochem Biophys Res Commun·2009
8-other
Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2.
PMID 18852285·Mol Cell Biol·2008
7-preclinical
Erythropoiesis-stimulating agents in cancer.
PMID 18565902·J Clin Oncol·2008
8-other
Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation.
PMID 17616845·J Thromb Thrombolysis·2008
2-rct
Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
PMID 17579721·PLoS One·2007
7-preclinical
Erythropoietin protects cardiac myocytes against anthracycline-induced apoptosis.
PMID 17250809·Biochem Biophys Res Commun·2007
7-preclinical
Deferasirox versus deferoxamine.
PMID 16822908·Blood·2006
8-other
Erythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivity.
PMID 16505109·Mol Cancer Ther·2006
7-preclinical
Erythropoietin biology in cancer.
PMID 16428469·Clin Cancer Res·2006
6-review

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
DUKE UNIVERSITY MEDICAL CENTER, BOX 3912 DUMC
DURHAM, NC 27710

Location

Practice Location

DUKE UNIVERSITY MEDICAL CENTER, DURHAM, NC
(919) 668-6309

Quick Facts

NPI
1760420145
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile